🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#EKOS has excellent safety outcomes and is consistently proven, making it a first-line of #PE intervention. Learn more about how Dr. Bock uses EKOS as part of his toolkit to treat PE #WhyWeEKOS

Next week at #TCT2023: Reality Check New Perspectives on Endovascular Strategies for #PE Treatment. 🗓️Tuesday, October 24 @ 2:00PM (PT) Learn more: bit.ly/3RT96QE

Presented at #TCT2023 | REAL-PE, a study of over 2200 real-world #PE patients treated with #EKOS or FlowTriever—EKOS showed a statistically significant lower rate of major bleeding than patients treated with FlowTriever. Learn more: bit.ly/REAL-PE

LIVE | Reality Check: New Perspectives on Endovascular Strategies for #PE Treatment. Learn more about The REAL-PE Analysis: bit.ly/REAL-PE #MythShattered #WhyWeEKOS #TCT2023

HAPPENING NOW | Reality Check: New Perspectives on Endovascular Strategies to Successfully Treat #PE w/ Peter Monteleone, MD, FACC, FSCAI, Daniella KadianDodov, Robert A Lookstein MD, MHCDL, Christopher Semder, MD and DR MICHAEL R JAFF #VIVA23 Learn more about #REALPE: bit.ly/REAL-PE

Have you seen the results from the largest real-world and near real-time dataset evaluating advanced #PE therapies? Learn more about #REALPE here: bit.ly/REAL-PE #WhyWeEKOS #EvidenceBasedMedicine

Proud to announce the 300th patient enrollment in #HIPEITHO! #HIPEITHO is the first of its kind RCT trial in #PE and continues to show BSC’s commitment to #EvidenceBasedMedicine. #EKOS #WhyWeEKOS

“For a physician deciding in the moment which device might save a patient’s life, having that data to help guide their intuition could make a world of difference.” Learn more about #EKOS & the #REALPE analysis: bit.ly/42PgAI6 #WhyWeEKOS

Join our expert faculty to discuss strategies, treatment algorithms, & tool selection through case-based didactic presentations & breakout sessions addressing PE & arterial disease management. Register now to be a part of the conversation: cvent.me/yVz1X2 *US-based only

Don’t forget to register for our Vascular Master Class!

Thank you to all who made this incredible. Great to see you all! Jeff Mirviss Cat Jennings

Join me for a LinkedIn Live discussion on the Impact of Real-World Evidence on PE Treatment Options with Anas Safadi, MD and Dr. Patrick Troy. Make sure to attend it today at 11 AM CST. linkedin.com/events/impacto…

Very exciting news! #TCAR is at the forefront of innovation in #vascularmedicine enabling a clinically differentiated procedure to prevent stroke in patients with carotid artery disease. We look forward to Silk Road Medical joining BSC & PI! #vascularsurgery

#Fellows, join us to hear from a panel of world-class faculty as they give an in-depth educational experience on key interventional tools and techniques through case-based didactic presentations and hands-on training. Register now: cvent.me/DgkyER #MedEd #vasctwitter

Join us as we examine the future of clinical & real-world data & address #PE & arterial disease management. Expert faculty will discuss strategies, treatment algorithms, & tool selection through case-based didactic presentations & more. Register today: cvent.me/DLKx0g

We are proud to announce that the 400th patient has been enrolled in #HIPEITHO! HI-PEITHO is the first rigorous international prospective RCT with hard, meaningful endpoints in #PE and continues to show BSC’s commitment to #EvidenceBasedMedicine. #EKOS #WhyWeEKOS

Clear evidence of BSC's commitment to patients with vascular diseases, the physicians who care for them, and innovation at the forefront.

Headed to #TheVEINS24 and #VIVA24? Don't miss these Boston Scientific events! 🗓️ The VEINS Meeting The VIVA Foundation Jeff Mirviss

Excited to share that our dedicated investigators, The PERT Consortium® & Universitätsmedizin Mainz, have enrolled the 500th patient in #HIPEITHO! HI-PEITHO is the seminal global prospective multicenter RCT with primary endpoints that will be meaningful to all who manage patients with #PE